The global multiple myeloma drugs market is anticipated to grow at a CAGR of nearly 5.2% during the forecast period (2022-2028). Multiple myeloma is an uncommon type of blood cancer in which abnormal plasma cells build up in the bone marrow and form tumors in many bones of the body. This form of cancer prevents […]
